Skip to main content
SURMODICS INC logo

SURMODICS INC — Investor Relations & Filings

Ticker · SRDX ISIN · US8688731004 LEI · 549300H76KXCAAGUS878 US Manufacturing
Open in API
Filings indexed 1,062 across all filing types
Latest filing 2011-12-02 Director's Dealing
Country US United States of America
Listing US SRDX

About SURMODICS INC

https://www.surmodics.com/

Surmodics, Inc. provides performance-enhancing technologies for the healthcare industry, focusing on medical devices and in vitro diagnostics. The company is a leading provider of surface modification technologies, offering customized hydrophilic, hemocompatible, and drug-delivery coatings for intravascular medical devices. In addition to its coatings business, Surmodics develops and commercializes a portfolio of vascular intervention medical devices for the treatment of peripheral arterial and venous disease, including thrombectomy and radial access platforms. The company also offers end-to-end contract development and manufacturing services. Its In Vitro Diagnostics (IVD) division supplies critical chemical components for immunoassays and microarrays, aiming to enhance the sensitivity and reproducibility of diagnostic tests.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2011-12-02 English
4 Filing
Director's Dealing
2011-12-02 English
4 Filing
Director's Dealing
2011-12-02 English
4 Filing
Director's Dealing
2011-12-02 English
SURMODICS, INC. 8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 29, 2011, by SurModics, Inc. The key content is the announcement of a presentation at Piper Jaffray’s 23rd Annual Healthcare Conference, with slides attached as Exhibit 99.1. The text explicitly states that the presentation materials are furnished pursuant to Item 7.01 of Form 8-K and that the presentation will be made available on the company's website. The document includes forward-looking statements and non-GAAP financial information, typical for investor presentations. There are no detailed financial statements or comprehensive analysis typical of an Interim Report or Annual Report. The document is primarily a presentation material filing, not a full report or earnings release. Therefore, the best classification is Investor Presentation (IP). The document length (6191 characters) supports it being a presentation rather than a brief announcement or a full report.
2011-11-29 English
8-K Filing
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes the completion of an acquisition/disposition of assets, specifically the sale of a subsidiary's assets. It includes references to an Asset Purchase Agreement and pro forma financial information related to the transaction. There is no full financial report or detailed earnings data presented, but rather a regulatory announcement of a significant corporate event. This fits the category of M&A Activity (TAR) filings, which cover announcements and documents related to merger proposals or takeover bids. The document is not an Annual Report, Earnings Release, or other financial report type, but a regulatory filing announcing a transaction. Therefore, the correct classification is TAR with high confidence.
2011-11-21 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.